Test Price
2,800 AED✅ Home Collection Available
WDR62 Gene Microcephaly with Cortical Malformations, Autosomal Recessive Type 2 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
This comprehensive genetic test provides definitive molecular diagnosis for WDR62-related primary microcephaly type 2 with cortical malformations, adhering to the highest clinical and legal standards in the UAE.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM – 11 PM.
- Clinical Guidance: Telephonic post-test result interpretation from our DHA-licensed genetics expert.
- Insurance & Licensing: Direct Billing Verification via WhatsApp +971 54 548 8731 | DHA Facility License: 1143.
Test Overview & Methodology
This NGS-based genetic test examines the entire WDR62 gene to identify pathogenic variants causing autosomal recessive primary microcephaly type 2 with cortical malformations, enabling definitive molecular diagnosis and informed clinical management. The test is performed at DNA Labs UAE, an ISO 9001:2015 certified laboratory.
| Parameter | Our Test (ISO 9001:2015) | Closest Alternative |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) with full gene coverage, including intron-exon boundaries | Targeted Sanger sequencing (single exon) or chromosomal microarray (no gene-level resolution) |
| Diagnostic Sensitivity | >99.9% for single nucleotide variants and small indels within WDR62 | ~85% (microarray) or limited to known hotspots |
| Turnaround Time | 3 to 4 Weeks | 4-6 Weeks (may require reflex testing) |
| Sample Flexibility | Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) | Often restricted to whole blood |
Physician Insight & Safety Protocols
“A confirmed genetic diagnosis of WDR62-related microcephaly brings clarity to families and guides neurodevelopmental support, surveillance for cortical dysplasia, and recurrence risk counseling. We emphasize that results must be interpreted in the context of detailed brain imaging and clinical findings. Our multidisciplinary team stands with you throughout the diagnostic journey.”
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory: Medication & Pre-Test Instructions
Do not discontinue any prescribed medications without consulting your treating physician. Inform our phlebotomist of all current medications and supplements prior to sample collection to ensure accurate test interpretation and avoid potential interactions.
Exclusion Criteria & Emergency Red Flags
- Patients with active high fever, severe respiratory distress, or hemodynamic instability should postpone home collection and seek immediate medical attention.
- If the child experiences new-onset seizures, altered consciousness, or signs of raised intracranial pressure (bulging fontanelle, forced downward gaze), proceed to the nearest emergency department.
- Sample collection must be performed by our certified phlebotomist; self-collection is not permitted for infants.
Patient FAQ & Clinical Guidance
1. What is the WDR62 gene test and who should consider it?
This genetic test uses next-generation sequencing to detect WDR62 mutations causing autosomal recessive microcephaly type 2. It is clinically indicated for newborns and infants presenting with severe congenital microcephaly (head circumference < -3 SD), cortical malformations on neuroimaging, and a family history suggesting recessive inheritance. Pediatricians, neonatologists, and clinical geneticists are the primary specialists who order this test after thorough clinical and radiological evaluation.
2. How is the sample collected and how long do results take?
A small blood sample, extracted DNA, or a dried blood spot on an FTA card is collected at your home via our VIP mobile phlebotomy team (daily 8 AM – 11 PM). The sample is transported under temperature-controlled cold chain to our ISO 9001:2015 certified laboratory. Turnaround time is 3 to 4 weeks. A completed clinical history form and a pedigree chart from a genetic counseling session must accompany the sample.
3. Is this test covered by insurance in the UAE?
Most UAE insurance plans cover medically necessary genetic testing for congenital anomalies when preauthorized by a pediatric neurologist or geneticist. We verify your direct billing eligibility and handle approvals prior to collection. Contact our support team on WhatsApp at +971 54 548 8731; we respond within minutes to provide a confirmation of your coverage and out-of-pocket estimate.
UAE Regulatory & Data Privacy Adherence
All genetic data and personal health information are processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is a DHA-licensed facility (License 1143) operating under the highest standards of confidentiality and ethical practice.
Clinical & Logistical Metadata
| Test Name | WDR62 Gene Microcephaly with Cortical Malformations, Autosomal Recessive Type 2 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | Q02, Q04.8 |
| LOINC Code | 86709-3 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians